Abstract
In order to understand the role exerted by the endogenous somatostatinergic tone in the blunting of GH responsiveness to repeated GHRH administration, we evaluated GH responses to the second GHRH bolus during a simultaneous infusion of galanin, which has been reported to inhibit the endogenous somatostatin release. Seven normal adults (3M/4F, age range 19–28 yr), admitted to the study after giving informed consent, were tested on three occasions, with a) two consecutive 1 μg/kg iv GHRH boluses administered at 0 min and 120 min, b) one GHRH bolus at 0 min followed by an infusion of 10 μ/kg bw galanin (diluted in 40 ml 0.9% NaCI) between 100 min and 140 min and c) two consecutive GHRH boluses (same dose and temporization of administration of test a) associated with a galanin infusion from 100 min to 140 min. GH responses were evaluated as the net incremental area under the curve (GH nAUC/h); all data were expressed as mean±SE. GH responses to the first GHRH bolus were similar in the three tests (mean GH nAUC, test A 990±80, test B: 1006±112, test C: 1077±80 ng/ml/h). In test A the second GHRH bolus was unable to sustain GH elevated levels (mean GH nAUC: 32±12 ng/ml/h vs first GHRH: 990±80 ng/ml/h, p<0.0001). Similarly, in test B galanin infusion alone was unable to determine a clear GH rise (mean GH nAUC: −25±16 vs first GHRH: 1006±112 ng/ml/h, p<0.0001). In test C, the concomitant galanin infusion enhanced GH responsiveness to the second GHRH bolus (mean GH nAUC: 407±73 ng/ml/h vs GHRH alone: 32±12 ng/ml/h, p<0.005), GH responses being however lower than after the first GHRH administration (p<0.0001). In conclusion, our data show that simultaneous galanin infusion partially restores GH response to the second GHRH bolus in normal adults, thus indicating that the depletion of the intracellular GH pool can not completely account for the reduction of GH responsiveness.
Similar content being viewed by others
References
Sartorio A., Spada A., Morabito F., Faglia G. Different GH responsiveness to repeated GHRH administration in normal children and adults. J. Endocrinol. Invest. 11: 727, 1988.
Ghigo E., Goffi S., Mazza E., Arvat E., Procopio M., Bellone J., Muller E.E., Camanni F. Repeated GH-releasing hormone administration unravels different GH secretory patterns in normal adults and children. Acta Endocrinol. (Copenh.) 120: 598, 1989.
Sartorio A., Spada A., Arosio M., Conti A., Faglia G., De Nicolao G. Effects of consecutive doses of GHRH on GH secretion. Clin. Endocrinol. (Oxf.) 35: 187, 1991.
Losa M., Bock L., Schopohl J., Stalla G.K., Müller O.A., Von Werder K. Growth hormone releasing factor infusion does not sustain elevated GH levels in normal subjects. Acta Endocrinol. (Copenh.) 107: 462, 1984.
Vance M.L., Kaiser D.L., Evans W.S., Thorner M.O., Furlanetto R., Rivier J., Vale W., Perisutti G., Frohman L.A. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man. J. Clin. Endocrinol. Metab. 60: 370, 1985.
Bilezjian L.M., Vale W.W. Chronic exposure of cultured rat anterior pituitary cells to GRF causes partial loss of responsiveness to GRF. Endocrinology 115: 2032, 1984.
Ceda G.P., Hoffman A.R. Growth hormone-releasing factor desensitization in rat anterior pituitary cells in vitro. Endocrinology 116: 1334, 1985.
Massara F., Ghigo E., Molinatti P., Mazza E., Locatelli V., Muller E.E., Camanni F. Potentiation of cholinergic tone by pyridostigmine bromide reinstates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. Acta Endocrinol. (Copenh.) 113: 12, 1986.
Simard J., Lefevre G., Labrie F. Somatostatin prevents the desensitizing action of growth hormone-releasing factor on growth hormone release. Peptides 8: 199, 1987.
Murakami Y., Kato Y., Koshiyama H., Inoue T., Yanaihara N., Imura H. Galanin stimulates growth hormone (GH) secretion via GH-releasing factor (GRF) in conscious rats. Eur. J. Pharmacol. 136: 415, 1987.
Ottlecz A., Samson W.K., Mc Cann S.M. Galanin: evidence for a hypothalamic site of action to release growth hormone. Peptides 7: 51, 1986.
Meister B., Hulting A.L. Influence of coexisting hypothalamic messengers on growth hormone secretion from rat anterior pituitary cells in vitro. Neuroendocrinology 46: 387, 1987.
Bauer F.E., Ginsberg L., Venetikou M., Mackay D.J., Burrin J.M., Bloom S.R. Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet. 2: 192, 1986.
Davis T.M.E., Burrin J.M., Bloom S.R. Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. J. Clin. Endocrinol. Metab. 65: 1248, 1987.
Chatterjee V.K.K., Ball J.A., Proby C., Burrin J.M., Bloom S.R. Galanin abolishes the inhibitory effect of cholinergic blockade on growth hormone-releasing hormone-induced secretion of growth hormone in man. J. Endocrinol. 116: R1–R2, 1987.
Loche S., Vista N., Ghigo E., Vannelli S., Arvat E., Benso L., Corda R., Cella S. G., Muller E.E., Pintor C. Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children. Pediatr. Res. 27: 405, 1990.
Coiro V., D’Amato L., Borciani E., Rossi G., Cammellini L., Maffei M.C., Pignatti D., Chiodera P. Nicotine from cigarette smoking enhances clonidine-induced increase of serum growth hormone concentrations in man. Br. J. Pharmacol. 18: 802, 1984.
Arvat E., Ghigo E., Nicolosi M., Boffano G.M., Bellone J., Yin-Zhang W., Mazza E., Camanni F. Galanin reinstates the growth hormone response to repeated growth hormone-releasing hormone administration in man. Clin. Endocrinol. (Oxf.) 36: 347, 1992.
Murukami Y., Kato Y., Shimatsu A., Koshiyama H., Hattori N., Yanaihara N., Imura H. Possible mechanisms involved in growth hormone secretion induced by galanin in the rat. Endocrinology 124: 1224, 1989.
Shibasaki T., Hotta M., Masuda A., Imaki T., Obara N., Demura H., Ling N., Shizume K. Plasma growth hormone responses to growth hormone-releasing hormone and insulin-induced hypoglycemia in man. J. Clin. Endocrinol. Metab. 60: 1265, 1985.
Hülse J.A., Rosenthal S.M., Cuttler L., Kaplan S.L., Grumbach M.M. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men. J. Clin. Endocrinol. Metab. 63: 872, 1986.
Suri D., Hindmarsh P.C., Matthews D.R., Brain C.E., Brook C.G.D. The pituitary gland is capable of responding to two successive doses of growth hormone releasing hormone (GHRH). Clin. Endocrinol. (Oxf.) 34: 17, 1991.
Author information
Authors and Affiliations
Additional information
This work was partially supported by Progetti di Ricerca Corrente, Centra Auxologico Italiano, IRCCS, Milan, Italy and by Consiglio Nazionale delle Ricerche, Rome, Italy (grant no. 89.03407.14.1)
Rights and permissions
About this article
Cite this article
Sartorio, A., Spada, A., Conti, A. et al. Galanin infusion partially restores the blunted growth hormone responses to repeated growth hormone releasing hormone stimuli in normal adults. J Endocrinol Invest 16, 95–98 (1993). https://doi.org/10.1007/BF03347656
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347656